Perimeter Medical Imaging AI Inc.

Perimeter Medical Imaging AI Inc. is a medical technology company dedicated to transforming cancer surgery through advanced imaging systems. The company's core mission is to improve the standard of care, enhance long-term patient outcomes, and reduce healthcare costs by minimizing the need for repeat surgeries caused by residual cancer. Headquartered in Toronto, Canada, with U.S. operations in Dallas, Texas, Perimeter Medical Imaging AI aims to provide surgeons with real-time, high-resolution insights during operations.

The company's primary offering is the FDA-cleared Perimeter S-Series Optical Coherence Tomography (OCT) system, which delivers ultra-high-resolution, cross-sectional visualization of excised tissue specimens in the operating room. Perimeter is also actively developing its next-generation Perimeter B-Series OCT with ImgAssist AI, an investigational technology that integrates artificial intelligence to further optimize and accelerate surgeons' decision-making, particularly in breast cancer surgery.

Adrian Mendes was appointed Chief Executive Officer in June 2023, bringing extensive experience in scaling technology companies. The Perimeter B-Series OCT with ImgAssist AI has received U.S. FDA Breakthrough Device Designation and is supported by a significant grant from the Cancer Prevention and Research Institute of Texas. Recent developments include the company's selection for the INOVAIT Pilot Fund to advance AI for breast cancer surgery and a systemwide agreement with Intermountain Health to deploy its technology.